sbe.synapsing
ActiveSummary
sbe.synapsing has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,231 and a net result of €56,631. Equity is shrinking by ~7.5% per year across the filed fiscal years. Its solvency ranks better than 34% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency68▼-32
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,500 at 30 days acceptable
Liquidity ample (current ratio 1.53 against 7.23 in 2024; short-term debt: 56.9% and cash: 20.5% of total assets), but 57.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
42.8%
Return on assets
40.3%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 29-04-2026, 1 day ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
1 d early
2024
16 d late
2023
53 d early
2022
52 d early
2021
52 d early
2020
36 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 30 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 9 March (4 of the last 5 filed years within 51 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today30-09-2026 close30-04-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€60,231▼ 63.0%
2024 · €162,905
Total assets
€140,628▼ 25.8%
2024 · €189,607
Net result
€56,631▼ 60.2%
2024 · €142,445
Working capital
€42,218▼ 74.2%
2024 · €163,388
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€33,810▼ 71.3%€73,365▲ 117%€101,376▲ 38.2%€185,199▲ 82.7%€64,824▼ 65.0%
Net result€26,759within the sector's middle half▼ 71.0%€58,443within the sector's middle half▲ 118%€80,644within the sector's middle half▲ 38.0%€142,445above the sector's middle half▲ 76.6%€56,631within the sector's middle half▼ 60.2%
Equity€131,367within the sector's middle half▲ 25.6%€196,009within the sector's middle half▲ 49.2%€101,104within the sector's middle half▼ 48.4%€162,905within the sector's middle half▲ 61.1%€60,231within the sector's middle half▼ 63.0%
Total assets€142,606below the sector's middle half▼ 0.8%€214,841within the sector's middle half▲ 50.7%€112,860below the sector's middle half▼ 47.5%€189,607within the sector's middle half▲ 68.0%€140,628within the sector's middle half▼ 25.8%
Debt€11,239▼ 71.3%€18,831▲ 67.6%€11,755▼ 37.6%€26,702▲ 127%€80,397▲ 201%
Working capital€134,708within the sector's middle half▲ 27.7%€197,885within the sector's middle half▲ 46.9%€103,224within the sector's middle half▼ 47.8%€163,388within the sector's middle half▲ 58.3%€42,218within the sector's middle half▼ 74.2%
Solvency92.1%above the sector's middle half▲ 19.3pp91.2%above the sector's middle half▼ 0.9pp89.6%above the sector's middle half▼ 1.7pp85.9%above the sector's middle half▼ 3.7pp42.8%within the sector's middle half▼ 43.1pp
Current ratio18.06above the sector's middle half▲ 14.2212.67above the sector's middle half▼ 5.3911.71above the sector's middle half▼ 0.967.23above the sector's middle half▼ 4.481.53within the sector's middle half▼ 5.70
Return on assets (ROA)18.8%within the sector's middle half▼ 45.4pp27.2%within the sector's middle half▲ 8.4pp71.5%above the sector's middle half▲ 44.3pp75.1%above the sector's middle half▲ 3.7pp40.3%above the sector's middle half▼ 34.9pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 65% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €140,628
Fixed assets
€18,413
Current assets
€122,215
Equity and liabilities €140,628
Equity
€60,231 ▼ 63.0%
Debt
€80,397 ▲ 201%
Debt's share of the balance-sheet total rises from 14.1% to 57.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€68,370
Cash flow
€60,177
Debt to equity
1.33▲
2024 · 0.16
ROE
94.0%▲
2024 · 87.4%
Interest coverage
1536.06
Debt ≤ 1 year
€79,998▲
2024 · €26,218
Income taxes
€10,794▼
2024 · €42,700
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €5,000 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,038 | - | - | - | €3,546 | - |
| Other operating charges640/8 | - | €556 | €480 | €501 | €501 | ▲ 0.1% |
| Gross operating margin9900 | €35,299 | €73,921 | €101,856 | €185,700 | €68,871 | ▼ 62.9% |
| Operating profit (loss)9901 | €33,810 | €73,365 | €101,376 | €185,199 | €64,824 | ▼ 65.0% |
| Financial income75/76B | - | - | - | - | €2,645 | - |
| Recurring financial income75 | €8 | - | - | - | €2,645 | - |
| Financial charges65/66B | - | €94 | €93 | €54 | €45 | ▼ 17.7% |
| Recurring financial charges65 | €26 | €94 | €93 | €54 | €45 | ▼ 17.7% |
| Non-recurring financial charges66B | - | €94 | - | - | - | - |
| Profit (loss) for the period before taxes9903 | €33,727 | €73,271 | €101,283 | €185,145 | €67,425 | ▼ 63.6% |
| Income taxes67/77 | €6,968 | €14,828 | €20,639 | €42,700 | €10,794 | ▼ 74.7% |
| Profit (loss) for the period9904 | €26,759 | €58,443 | €80,644 | €142,445 | €56,631 | ▼ 60.2% |
| Profit (loss) for the period to be appropriated9905 | €26,759 | €58,443 | €80,644 | €142,445 | €56,631 | ▼ 60.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €142,606 | €214,841 | €112,860 | €189,607 | €140,628 | ▼ 25.8% |
| Fixed assets21/28 | - | - | - | - | €18,413 | - |
| Tangible fixed assets22/27 | - | - | - | - | €18,413 | - |
| Plant, machinery and equipment23 | - | - | - | - | €807 | - |
| Furniture and vehicles24 | - | - | - | - | €17,605 | - |
| Current assets29/58 | €142,606 | €214,841 | €112,860 | €189,607 | €122,215 | ▼ 35.5% |
| Amounts receivable within one year40/41 | €159 | - | €865 | - | €19,422 | - |
| Trade receivables40 | - | - | €865 | - | €245 | - |
| Other amounts receivable41 | - | - | - | - | €19,177 | - |
| Current investments50/53 | - | €13,000 | €13,000 | €32,400 | - | - |
| Cash at bank and in hand54/58 | €141,939 | €200,673 | €98,437 | €87,348 | €28,821 | ▼ 67.0% |
| Deferred charges and accrued income490/1 | - | €1,167 | €557 | €69,859 | €73,973 | ▲ 5.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €142,606 | €214,841 | €112,860 | €189,607 | €140,628 | ▼ 25.8% |
| Equity10/15 | €131,367 | €196,009 | €101,104 | €162,905 | €60,231 | ▼ 63.0% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €1,860 | €1,860 | €1,860 | €1,860 | - | - |
| Distributable reserves133 | - | €1,860 | €1,860 | €1,860 | - | - |
| Profit (loss) carried forward14 | €117,107 | €175,549 | €80,644 | €142,445 | €41,631 | ▼ 70.8% |
| Amounts payable17/49 | €11,239 | €18,831 | €11,755 | €26,702 | €80,397 | ▲ 201% |
| Amounts payable within one year42/48 | €7,897 | €16,955 | €9,636 | €26,218 | €79,998 | ▲ 205% |
| Financial debts43 | - | - | - | €472 | €472 | = |
| Credit institutions430/8 | - | - | - | €472 | €472 | = |
| Trade debts44 | €479 | €1,723 | €6,713 | €1,204 | €13 | ▼ 98.9% |
| Suppliers440/4 | - | €1,723 | €6,713 | €1,204 | €13 | ▼ 98.9% |
| Taxes, remuneration and social security45 | - | €14,828 | €639 | €17,700 | - | - |
| Taxes450/3 | - | €14,828 | €639 | €17,700 | - | - |
| Other amounts payable47/48 | - | €404 | €2,285 | €6,843 | €79,513 | ▲ 1,062% |
| Accrued charges and deferred income492/3 | - | €1,876 | €2,119 | €483 | €400 | ▼ 17.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €26,759 | €58,443 | €80,644 | €142,445 | €56,631 | ▼ 60.2% |
| + Depreciation and write-downs630 | €1,038 | - | - | - | €3,546 | - |
| Operating cash flow (approximation) | €27,797 | €58,443 | €80,644 | €142,445 | €60,177 | ▼ 57.8% |
| Change in cash | - | €58,735 | -€102,236 | -€11,090 | -€58,527 | ▼ 428% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
16-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 16 days late
2024
30-09
Financial
Highest result since 2020net €142,445 ▲76.6%
Operating result €185,199, net result €142,445, both a record.
30-09
Financial
Equity above €150,000Eq €162,905 ▲61.1%
5 profitable years in a row build equity to €162,905.
08-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
09-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-09
Financial
Equity above €150,000Eq €196,009 ▲49.2%
3 profitable years in a row build equity to €196,009.
09-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Weakest financial yearnet €26,759 ▼71%
Net result drops to €26,759, the lowest in the series; recovery starts the following year.
30-09
Financial
Liquidity times 5current ratio 18.06
Current ratio from 3.83 to 18.06; short-term debt falls from €37,231 to €7,897.
25-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoeilaart · 1 establishment unit since 2018
Ground area
2,264 m²
Building footprint
292 m²
Volume, LiDAR
2,632 m³
2 parcels, Flanders · tallest building 14.9 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
sbe.synapsing
since 20182.282.358.431
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24504E0262/00C002 | Flanders | 1,823 m² | 1 · 185 m² | 14.9 m · 4 fl. |
| 23033A0515/00V002 | Flanders | 441 m² | 1 · 108 m² | 11.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
699400KN1YTGLPA16725
Similar companies · same sector, comparable size
DR. VERWULGEN EEFJE
BE 1008.950.052
Schoten · Eq €60,203
Dr. Thomas De Ridder
BE 0800.917.716
Herentals · Eq €60,141
Vespanest
BE 1003.809.646
Herentals · Eq €60,325
BrousmicheK
BE 0755.706.214
Overijse · Eq €60,125
EAS-MED
BE 0738.882.454
Anderlecht · Eq €60,100
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 5,418 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded30-11-2018
Fiscal year end30-09
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0714962947
Also
9925:BE0714962947
Registered
12-02-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.